These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33221676)

  • 81. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous R486C mutation in CYP7B1 (SPG5).
    Höflinger P; Theurer Y; Schüle R; Schöls L; Hauser S
    Stem Cell Res; 2016 Sep; 17(2):422-425. PubMed ID: 27879216
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5).
    Hauser S; Höflinger P; Theurer Y; Rattay TW; Schöls L
    Stem Cell Res; 2016 Sep; 17(2):437-440. PubMed ID: 27879220
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Generation of two induced pluripotent stem cell lines (RCMGi004-A and -B) from human skin fibroblasts of a cystic fibrosis patient with compound heterozygous F508del/W1282X mutations in CFTR gene.
    Kondrateva E; Demchenko A; Slesarenko Y; Pozhitnova V; Yasinovsky M; Amelina E; Tabakov V; Voronina E; Lavrov A; Smirnikhina S
    Stem Cell Res; 2021 Apr; 52():102232. PubMed ID: 33607467
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Generation of a human induced pluripotent stem cell line (PHAi003) from a primary immunodeficient patient with CD70 mutation.
    Arias-Fuenzalida J; Yu J; Abolhassani H; Du L; Custodio J; Pan-Hammarström Q
    Stem Cell Res; 2019 Dec; 41():101612. PubMed ID: 31678777
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Dynamic transcriptional and epigenomic reprogramming from pediatric nasal epithelial cells to induced pluripotent stem cells.
    Ji H; Zhang X; Oh S; Mayhew CN; Ulm A; Somineni HK; Ericksen M; Wells JM; Khurana Hershey GK
    J Allergy Clin Immunol; 2015 Jan; 135(1):236-44. PubMed ID: 25441642
    [TBL] [Abstract][Full Text] [Related]  

  • 86. The generation of an induced pluripotent stem cell line (DCGi001-A) from an individual with FOXG1 syndrome carrying the c.460dupG (p.Glu154fs) variation in the FOXG1 gene.
    Waite AJ; Millar D; Clarke A
    Stem Cell Res; 2020 Dec; 49():102018. PubMed ID: 33096386
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Generation of Stable Induced Pluripotent Stem-like Cells from Adult Zebra Fish Fibroblasts.
    Peng L; Zhou Y; Xu W; Jiang M; Li H; Long M; Liu W; Liu J; Zhao X; Xiao Y
    Int J Biol Sci; 2019; 15(11):2340-2349. PubMed ID: 31595152
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Infections in activated PI3K delta syndrome (APDS).
    Brodsky NN; Lucas CL
    Curr Opin Immunol; 2021 Oct; 72():146-157. PubMed ID: 34052541
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Generation and characterization of a human iPSC line SANi006-A from a Gray Platelet Syndrome patient.
    Aarts CEM; Varga E; Webbers S; Geissler J; von Lindern M; Kuijpers TW; van den Akker E
    Stem Cell Res; 2021 Aug; 55():102443. PubMed ID: 34237592
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Generation of iPSC line (USTCi001-A) from human skin fibroblasts of a patient with epilepsy.
    Zhao H; Li S; He L; Han X; Huang H; Tang F; Lin Z; Deng S; Tian C; Huang R; Li Z
    Stem Cell Res; 2020 May; 45():101785. PubMed ID: 32335389
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Derivation, Expansion, and Motor Neuron Differentiation of Human-Induced Pluripotent Stem Cells with Non-Integrating Episomal Vectors and a Defined Xenogeneic-free Culture System.
    Hu W; He Y; Xiong Y; Lu H; Chen H; Hou L; Qiu Z; Fang Y; Zhang S
    Mol Neurobiol; 2016 Apr; 53(3):1589-1600. PubMed ID: 25663198
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Generation of germ cells in vitro in the era of induced pluripotent stem cells.
    Imamura M; Hikabe O; Lin ZY; Okano H
    Mol Reprod Dev; 2014 Jan; 81(1):2-19. PubMed ID: 23996404
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Generation of two iPS cell lines (FRIMOi003-A and FRIMOi004-A) derived from Stargardt patients carrying ABCA4 compound heterozygous mutations.
    Riera M; Patel A; Burés-Jelstrup A; Corcostegui B; Chang S; Pomares E; Corneo B; Sparrow JR
    Stem Cell Res; 2019 Apr; 36():101389. PubMed ID: 30798147
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Human iPS cell-derived fibroblast-like cells as feeder layers for iPS cell derivation and expansion.
    Du SH; Tay JC; Chen C; Tay FC; Tan WK; Li ZD; Wang S
    J Biosci Bioeng; 2015 Aug; 120(2):210-7. PubMed ID: 25622768
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Reprogramming and differentiation-dependent transcriptional alteration of DNA damage response and apoptosis genes in human induced pluripotent stem cells.
    Shimada M; Tsukada K; Kagawa N; Matsumoto Y
    J Radiat Res; 2019 Nov; 60(6):719-728. PubMed ID: 31665364
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1.
    Tubsuwan A; Pires C; Rasmussen MA; Schmid B; Nielsen JE; Hjermind LE; Hall V; Nielsen TT; Waldemar G; Hyttel P; Clausen C; Kitiyanant N; Freude KK; Holst B
    Stem Cell Res; 2016 Jan; 16(1):110-2. PubMed ID: 27345792
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Generation of an induced pluripotent stem cell line (CSC-44) from a Parkinson's disease patient carrying a compound heterozygous mutation (c.823C>T and EX6 del) in the PARK2 gene.
    Marote A; Pomeshchik Y; Goldwurm S; Collin A; Lamas NJ; Pinto L; Salgado AJ; Roybon L
    Stem Cell Res; 2018 Mar; 27():90-94. PubMed ID: 29353703
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Generation of an induced pluripotent stem cell line HPCASRi002-A from a patient with neonatal severe primary hyperparathyroidism caused by a compound heterozygous mutation in the CASR gene.
    Panova AV; Kulikova KS; Klementieva NV; Krylov ID; Snezhko IO; Tiulpakov AN; Kiselev SL
    Stem Cell Res; 2021 Jul; 54():102414. PubMed ID: 34111698
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells.
    Zhou W; Freed CR
    Stem Cells; 2009 Nov; 27(11):2667-74. PubMed ID: 19697349
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Establishment of an induced pluripotent stem (iPS) cell line from dermal fibroblasts of an asymptomatic patient with dominant PRPF31 mutation.
    Terray A; Fort V; Slembrouck A; Nanteau C; Sahel JA; Reichman S; Audo I; Goureau O
    Stem Cell Res; 2017 Dec; 25():26-29. PubMed ID: 29040912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.